Clinical Trials Sponsored by NETwerk, Belgium

Total 4753 results

Institute of Tropical Medicine, Belgium

Completed

Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in Peru

Malaria
Virometix
Center of Vaccinology, Ghent, Belgium (CEVAC); Expert Clinical Services Organization...

Completed

Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus

Acute Bronchiolitis Due to Respiratory Syncytial Virus

Belgium
University Hospital, Ghent
VZW kinderkankerfonds, Belgium

Recruiting

Multidisciplinary Rehabilitation of Children and Adolescents After Acute Cancer Treatment

Rehabilitation | Exercise Therapy | Cancer Survivors

Belgium
Laboratory of Movement, Condorcet, Tournai, Belgium

Unknown

Effect on paO2 of Adding an Aerosol Mask Above the Nasal Canulas

Emergencies | Covid19 | Hypoxemic Respiratory Failure

Belgium
Laboratory of Movement, Condorcet, Tournai, Belgium

Completed

Double Trunk Mask and Standard Nasal Cannula During Acute Hypoxia

Hypoxia

Belgium
Laboratory of Movement, Condorcet, Tournai, Belgium

Completed

Effect of a Modified Oxygen Mask Associated to Nasal Prongs During a High Flow Oxygenation Method

Oxygen Inhalation Therapy

Belgium
Laboratory of Movement, Condorcet, Tournai, Belgium

Completed

Does Obesity Influence Women Cardiorespiratory Fitness and Daily Physical Activities? (ACTIVOB) (ACTIVOB)

Obesity

Belgium
University Ghent
Special Research Fund, Belgium

Completed

Effect Study of an Eccentric Training Program and Stretching for Patients With Chronical Rotator Cuff Tendinopathy

Chronical Rotator Cuff Tendinopathy

Belgium
University Ghent
Fund for Scientific Research, Flanders, Belgium; International Centre for Reproductive...

Completed

Intimate Partner Violence and Pregnancy, a Perinatal Care Intervention Study (MOM)

Intimate Partner Violence

Belgium
Centre Oscar Lambret
Anticancer Fund, Belgium

Completed

Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas (FLUVABREX)

Glioma

France
Sciensano
Institute of Tropical Medicine, Belgium

Completed

COVID-19 Among Healthcare Workers in Belgian Hospitals (COVHECBEHO)

COVID-19 | SARS-CoV-2

Belgium
Yale University
Janssen Pharmaceutica N.V., Belgium

Completed

Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics

Diabetes Mellitus | Schizophrenia | Bipolar Disorder
Université Libre de Bruxelles
Fonds National de la Recherche Scientifique; Belgium: Belgian Federal Science...

Completed

Sensory Stimulation Effect on Movement Speed in Patients With Parkinson Disease

Parkinson Disease

Belgium
iTeos Belgium SA
GlaxoSmithKline; iTeos Therapeutics

Recruiting

Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors (TIG-006)

Melanoma | Head and Neck Cancer | Lung Cancer | Advanced Cancer

Spain, Italy, France, United States, United Kingdom, Belgium
Institute of Tropical Medicine, Belgium
Sciensano

Completed

Development and Implementation of an HIV-testing Intervention for Primary Care in Belgium

HIV Infections

Belgium
NewVac LLC
Janssen Pharmaceutica N.V., Belgium

Completed

Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Ovarian Cancer

Russian Federation
NewVac LLC
Janssen Pharmaceutica N.V., Belgium

Completed

Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Epithelial Ovarian Cancer | Non-small Cell Lung Cancer

Russian Federation
Institute of Tropical Medicine, Belgium
University Ghent; Nutrition Third World, Belgium; Flemish Interuniversity Council...

Completed

Effect of Prenatal Nutritional Supplementation on Birth Outcome in Hounde District, Burkina Faso (MISAME2)

Low Birth Weight | Intrauterine Growth Retardation

Burkina Faso
Bellicum Pharmaceuticals

Terminated

Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases

Hemoglobinopathies | Hemophagocytic Lymphohistiocytosis | Metabolic Disorders | Primary Immune Deficiency Disorders | Inherited Bone Marrow Failure Syndrome

United States
Bellicum Pharmaceuticals

Terminated

Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant

Lymphoma, Non-Hodgkin | Acute Lymphoblastic Leukemia | Primary Immunodeficiency | Anemia, Sickle Cell | Hemoglobinopathies | Fanconi Anemia | Anemia, Aplastic | Myelodysplastic Syndrome | Thalassemia | Cytopenia | Diamond Blackfan Anemia | Osteopetrosis | Leukemia, Acute Myeloid (AML), Child

United Kingdom, Italy
Bellicum Pharmaceuticals

Terminated

Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study

Lymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Primary Immunodeficiency | Anemia, Sickle Cell | Hemoglobinopathies | Fanconi Anemia | Anemia, Aplastic | Thalassemia | Cytopenia | Diamond Blackfan Anemia | Leukemia, Acute Myeloid (AML), Child

Italy
Bellicum Pharmaceuticals

Withdrawn

Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT

Myelodysplastic Syndromes | Leukemia | Multiple Myeloma | Lymphomas | Other High-risk Hematological Malignancies
Bellicum Pharmaceuticals

Withdrawn

Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies

Hematologic Malignancies

United States
Bellicum Pharmaceuticals

No longer available

BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 Study

Hurler Syndrome | Inborn Errors of Metabolism | Metachromatic Leukodystrophy | Inherited Metabolic Disorder | Lysosomal Storage Disorder

United States
Bellicum Pharmaceuticals

Suspended

Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors

HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Solid Tumor, Adult | HER-2 Gene Amplification | HER-2 Protein Overexpression

United States
Bellicum Pharmaceuticals

Active, not recruiting

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

Lymphoma | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia

United States
Bellicum Pharmaceuticals

Active, not recruiting

Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant

Hematologic Malignancy

Italy
Bellicum Pharmaceuticals

Active, not recruiting

Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

Lymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Anemia, Aplastic | Primary Immune Deficiency Disorder | Cytopenia | Osteopetrosis | Leukemia, Acute Myeloid (AML), Child | Hemoglobinopathy in Children

United States
Bellicum Pharmaceuticals

Completed

Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer

Castrate Resistent Prostate Cancer

United States
Bellicum Pharmaceuticals

Terminated

Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal Melanoma

Acute Myeloid Leukemia | Myelodysplastic Syndrome | Uveal Melanoma

United States
Bellicum Pharmaceuticals

Terminated

Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS (THRIVE)

Acute Myeloid Leukemia | Myelodysplastic Syndromes

United States
Bellicum Pharmaceuticals

Suspended

Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors

Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate Cancer

United States
Bellicum Pharmaceuticals

Active, not recruiting

Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Hematologic Neoplasms | Multiple Myeloma

United States
Université Catholique de Louvain
Anticancer Fund, Belgium

Completed

Ketorolac in Breast Cancer Surgery (KBCt)

Curative Breast Cancer Surgery | Inflammatory Positive/Negative Status | Pre Surgical Incision Administration

Belgium
Institute of Tropical Medicine, Belgium
Novosanis NV

Completed

Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs (Colli-Pee)

Sexually Transmitted Diseases, Bacterial

Belgium
Centre Muraz
Institute of Tropical Medicine, Belgium

Completed

In Vivo and in Vitro Efficacy of Antimalarial Treatments in Children in Burkina Faso

Malaria

Burkina Faso
Centre Muraz
Institute of Tropical Medicine, Belgium

Completed

Amodiaquine+Artesunate for Uncomplicated Malaria Treatment (ASAQ-MAL)

Uncomplicated Malaria

Burkina Faso
University of Liege
Centre Hospitalier Neurologique William Lennox (Belgium); Hôpital Valdor -... and other collaborators

Recruiting

Apomorphine in Severe Brain-injured Patients (APODoC)

Disorder of Consciousness

Belgium, Spain
Universitaire Ziekenhuizen KU Leuven
MSD Belgium BVBA

Recruiting

The Effect of Deep Neuromuscular Block and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity in Shoulder Surgery Using a Deltopectoral Approach

Shoulder Pain | Anesthesia

Belgium
University Hospital Regensburg
Celgene; Anticancer Fund, Belgium

Terminated

Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML (AML-ViVA)

Acute Myeloid Leukemia

Germany
Institute of Tropical Medicine, Belgium
Damien Foundation

Active, not recruiting

Novel Triple-dose Tuberculosis Retreatment Regimen (Tri-Do-Re)

Tuberculosis | Pulmonary Tuberculosis | Multidrug-resistant Tuberculosis | Resistance to Tuberculostatic Drugs

Niger
The Netherlands Cancer Institute
Anticancer Fund, Belgium

Completed

Propranolol in Angiosarcoma

Angiosarcoma

Netherlands
Institute of Tropical Medicine, Belgium
Damien Foundation

Completed

Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2) (BE-PEOPLE P2)

Leprosy

Comoros
Institute of Tropical Medicine, Belgium
Damien Foundation

Withdrawn

Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More (TriDoRe)

Tuberculosis, Pulmonary

Bangladesh
Makerere University
Institute of Tropical Medicine, Belgium

Unknown

Intervention Trial to Measure the Effect of Individual Prenatal Information Combined With Mobile Phones

Pregnancy

Uganda
University Hospital, Lille
Janssen Pharmaceutica N.V., Belgium

Not yet recruiting

Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma (IFM2021-01)

Multiple Myeloma
Khondrion BV
Drug Research Unit Ghent, Belgium

Completed

A Dose-escalating Clinical Trial With KH176

Mitochondrial Disease | MELAS | Leigh Syndrome | LHON | Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation

Belgium
Tracon Pharmaceuticals Inc.
Janssen Pharmaceutica N.V., Belgium

Completed

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

Metastatic Castrate-resistant Prostate Cancer | Adenocarcinoma, Prostate

United States
UCB Pharma SA, Belgium
Parexel

Completed

A Study of Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid Arthritis (RAPID-C)

Rheumatoid Arthritis

China
Centre Muraz
Institute of Tropical Medicine, Belgium

Completed

Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso

Malaria

Burkina Faso

Clinical Trials Sponsored by NETwerk, Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations